Literature DB >> 2173332

Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia.

E Masliah1, D Galasko, C A Wiley, L A Hansen.   

Abstract

A 62-year-old man presented with memory impairment progressing over 6 years to dementia with near mutism and was diagnosed as having Alzheimer's disease. At autopsy his brain showed lobar atrophy suggestive of Pick's disease and there were spherical intracytoplasmic neuronal inclusions in the fascia dentata, hippocampal pyramidal cell layer, and temporal cortex. Unlike Pick bodies, however, the inclusions were eosinophilic with H&E stains, non-argyrophilic, and failed to react immunohistochemically with antibodies to paired helical filaments or Alz-50. They did label with antibodies to ubiquitin, however, and electron microscopy disclosed dense-cored granular structures with thin filamentous coronas which resembled brain stem-type Lewy bodies. The substantia nigra and locus coeruleus were not affected.

Entities:  

Mesh:

Year:  1990        PMID: 2173332     DOI: 10.1007/BF00307702

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

1.  Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case report.

Authors:  K Ikeda; S Ikeda; T Yoshimura; H Kato; M Namba
Journal:  Acta Neuropathol       Date:  1978-02-20       Impact factor: 17.088

2.  Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

Authors:  S M Ditter; S S Mirra
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

3.  Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.

Authors:  J K Tiller-Borcich; L S Forno
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

4.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

Authors:  K Kosaka; M Yoshimura; K Ikeda; H Budka
Journal:  Clin Neuropathol       Date:  1984 Sep-Oct       Impact factor: 1.368

5.  Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study.

Authors:  D Munoz-Garcia; S K Ludwin
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

6.  Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".

Authors:  M Yoshimura
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

7.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

8.  A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change.

Authors:  L A Hansen; E Masliah; R D Terry; S S Mirra
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Juvenile Parkinson's disease with widespread Lewy bodies in the brain.

Authors:  N Yoshimura; I Yoshimura; M Asada; S Hayashi; Y Fukushima; T Sato; H Kudo
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  9 in total
  3 in total

1.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2010-08-19       Impact factor: 17.088

2.  Diffuse Lewy body disease as substrate of primary lateral sclerosis.

Authors:  J A Hainfellner; P Pilz; H Lassmann; G Ladurner; H Budka
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

3.  Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissue.

Authors:  S M de la Monte; R A Spratt; J Chong; H A Ghanbari; J R Wands
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.